elvitegravir
Selected indexed studies
- Elvitegravir. (, 2006) [PMID:29999634]
- Elvitegravir. (, 2012) [PMID:31643247]
- Elvitegravir for the treatment of HIV. (Expert Opin Pharmacother, 2016) [PMID:27767362]
_Worker-drafted node — pending editorial review._
Connections
elvitegravir is a side effect of
Sources
- Elvitegravir. (2006) pubmed
- Elvitegravir. (2012) pubmed
- Elvitegravir for the treatment of HIV. (2016) pubmed
- Elvitegravir: a new HIV integrase inhibitor. (2009) pubmed
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection. (2016) pubmed
- Elvitegravir: a once-daily inhibitor of HIV-1 integrase. (2012) pubmed
- Elvitegravir: a review of its use in adults with HIV-1 infection. (2014) pubmed
- Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults. (2016) pubmed
- Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment. (2012) pubmed
- Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatment. (2014) pubmed